SIGNPATH PHARMA, INC. Retained Earnings
SIGNPATH PHARMA, INC. had Retained Earnings of -$16.13 million as of 2016-06-30, per its 10-Q filed 2016-08-15.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2016-08-15
- 2016-06-30: Retained Earnings (Accumulated Deficit) -$16.13M.
- 2016-03-31: Retained Earnings (Accumulated Deficit) -$15.45M.
- 2015-12-31: Retained Earnings (Accumulated Deficit) -$15.05M.
- 2015-09-30: Retained Earnings (Accumulated Deficit) -$14.78M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2016-06-30 | -$16.13M 10-Q · filed 2016-08-15 |
| 2016-03-31 | -$15.45M 10-Q · filed 2016-05-16 |
| 2015-12-31 | -$15.05M 10-Q · filed 2016-08-15 |
| 2015-09-30 | -$14.78M 10-Q · filed 2015-11-16 |
| 2015-06-30 | -$14.30M 10-Q · filed 2015-08-14 |
| 2015-03-31 | -$13.86M 10-Q · filed 2015-05-20 |
| 2014-12-31 | -$13.42M 10-K · filed 2016-04-08 |
| 2014-09-30 | -$12.81M 10-Q · filed 2014-11-14 |
| 2013-12-31 | -$10.67M 10-K · filed 2015-04-09 |